[en] The Tax proteins of the oncovirinae viruses are phosphorylated transcriptional activators that exhibit oncogenic potential. The role of phosphorylation in their functional activities remains unknown. As a model for the Human T-cell leukemia virus type I (HTLV-I), Bovine Leukemia Virus (BLV) permits the characterization of viral replication and leukemogenesis in vivo. Here, we show that the BLV Tax protein is phosphorylated on serine residues 106 and 293 both in insect and in mammalian cells. These sites can also be efficiently phosphorylated by the cdc2 and MAP kinases in vitro. Mutation of these residues does not affect the capacity of the Tax protein to function as a transactivator. Indeed, the Tax proteins mutated at one or both serines increase LTR-directed viral transcription at levels similar to those obtained with wild-type Tax in cell culture. Moreover, inhibition of Tax phosphorylation by W7, a calmodulin antagonist, does not alter its transactivation activity. Thus, phosphorylation on serines 106 and 293 is not required for transactivation by Tax. However, simultaneous substitution of both serines into alanine residues destroys the capacity of Tax to cooperate with the Ha-ras oncogene to transform primary rat embryo fibroblasts and induce tumors in nude mice. When the serines were replaced with aspartic acid residues, the oncogenic potential of Tax was maintained indicating that the negative charge rather than the phosphate group itself was required for Tax oncogenicity. Finally, to assess the role of the serine residues in vivo, recombinant viruses which express the Tax mutants were constructed and injected into sheep. It appeared that the mutated proviruses replicate at levels similar to the wild-type virus in vivo. We conclude that Tax phosphorylation is dispensable for transactivation and viral replication in vivo but is required for its oncogenic potential in vitro.
Akagi T, Ono H, Nyunoya H and Shimotohno K. (1997). Oncogene, 14, 2071-2078.
Baeuerle, P and Baltimore, D. (1988). Science, 242, 540-546.
Baranger A, Palmer R, Kay Hamm M, Giebler H, Brauweiler A, Nyborg J and Schepartz A. (1995). Nature, 376, 606-608.
Boros I, Tie F and Giam C. (1995). Virology 214, 207-214.
Chen G, Willems L, Portetelle D, Willard-Gallo K, Burny A and Kettmann R. (1989). Virology, 172, 343-347.
Cockerell G, Rovnak J, Green, P and Chen I. (1996). Blood, 87, 1030-1035.
Firzlaff J, Lüscher B and Eisenman R. (1991). Proc. Natl. Acad. Sci. USA, 88, 5187-5191.
Fontes J, Strawhecker J, Bills N, Lewis R and Hinrichs S. (1993). J. Virol., 67, 4436-4441.
Grassmann R, Dengler C, Muller-Fleckenstein J, Fleckenstein B, McGuire K, Dokhelar M, Sodroski J and Haseltine W. (1989). Proc. Natl. Acad. Sci. USA, 86, 3351-3355.
Green P, Ross T, Chen I and Pettiford S. (1995). J. Virol., 69, 387-394.
Grossman WJ, Kimata JT, Wong FH, Zutter M, Ley TJ and Ratner L. (1995). Proc. Natl. Acad. Sci. USA, 92, 1057-1061.
Henriksson M, Bakardjiev A, Klei G and Lüscher B. (1993). Oncogene, 8, 3199-3209.
Hidaka H, Sasaki Y, Tanaka T, Endo T, Ohno S, Fujii Y and Nagata T. (1981). Proc. Natl. Acad. Sci. USA, 75, 4354-4357.
Hunter T and Karin M. (1992). Cell, 70, 375-387.
Janknecht R, Hipskind R, Houthaeve T, Nordheim A and Stunnenberg H. (1992). EMBO J., 11, 1045-1054.
Kettmann R, Burny A, Callebaut I, Droogmans L, Mammerickx M, Willems L and Portetelle D. (1994). Bovine Leukemia Virus. In: The Retroviridae. JA Levy (ed). Plenum Press New York 3 pp. 39-81.
Luckow V and Summers M. (1988). Biotechnology, 6, 47-55.
Lüscher B, Christenson E, Lichtfield D, Krebs E and Eisenman R. (1990). Nature, 344, 517-522.
Manak J and Prywes R. (1991). Mol. Cell. Biol., 11, 3652-3659.
Marais R, Hsuan J, McGuigan C, Wynne J and Treisman R. (1992). EMBO J., 11, 97-105.
Matsumoto K, Shibata H, Fujisawa J-I, Inoue H, Hakura A, Tsukahara T and Fujii M. (1997). J. Virol., 71,. 4445-4451.
Nerenberg M, Hinrichs SH, Reynolds RK, Khoury G and Jay G. (1987). Science, 237, 1324-1329.
Nyunoya H, Akagi T, Ogura T, Maeda S and Shimotohno K. (1988). Virology, 167, 538-544.
Perini G, Wagner S and Green M. (1995). Nature, 376, 602-605.
Portetelle D, Mammerickx M and Burny A. (1989). J. Virol. Methods, 23, 211-222.
Pozzati R, Vogel J and Jay G. (1990). Mol. Cell. Biol., 10, 413-417.
Semmes O and Jeang KT. (1992). J. Virol., 66, 7183-7192.
Smeal T, Binétruy B, Mercola D, Birrer M and Karin M. (1991). Nature, 354, 494-496.
Smith M and Greene W. (1990). Genes Dev., 4, 1875-1885.
Studier F, Rosenberg A, Dunn J and Dubendorff J. (1990). Methods Enzymol., 185, 60-89.
Tanaka A, Takahashi C, Yamaoka S, Nosaka T, Maki M and Hatanaka M. (1990). Proc. Natl. Acad. Sci. USA, 87, 1071-1075.
Tratner I, Ofir R and Verma I. (1992). J. Virol., 12, 998-1006.
Tie F, Adya N, Greene W and Giam C. (1996). J. Virol., 70, 8368-8374.
Willems L, Heremans H, Chen G, Portetelle D, Billiau A, Burny A and Kettmann R. (1990). EMBO J., 9, 1577-1581.
Willems L, Grimonpont C, Heremans H, Rebeyrotte N, Chen G, Portetelle D, Burny A and Kettmann R. (1992). Proc. Natl. Acad. Sci. USA, 89, 3957-3961.
Willems L, Kettmann R, Dequiedl F, Portetelle D, Vonèche V, Cornil I, Kerkhofs P, Burny A and Mammerickx M. (1993). J. Virology, 67, 4078-4085.
Willems L, Kerkhofs P, Dequiedt F, Portetelle D, Mammerickx M, Burny A and Kettmann R. (1994). Proc. Natl. Acad. Sci. USA, 91, 11532-11536.
Yamaoka S, Inoue H, Sakurai M, Sugiyama T, Hazama M, Yamada T and Hatanaka M. (1996). EMBO J., 15, 873-887.
Yoshida M. (1996). J. AIDS and Hum. Retr., 13, S63-S68.
Zhao L and Giam C. (1992). Proc. Natl. Acad. Sci. USA, 89, 7070-7074.